European Medicines Agency

Canadian provinces suspended use of the Oxford-AstraZeneca COVID-19 vaccine in people under age 55 on Monday, March 29, 2021, acting on an advisory committee's concerns about a possible link between the shot and rare blood clots.

The National Advisory Committee on Immunization adjusted on Tuesday, March 16, 2021, its advice for the use of the Oxford-AstraZeneca vaccine to say that it can now be given to seniors.

The first COVID-19 vaccine could be approved for use in Canada within two weeks, Health Canada's chief medical adviser said on Thursday, November 26, 2020.